Literature DB >> 26589309

Novel Injectable Pentablock Copolymer Based Thermoresponsive Hydrogels for Sustained Release Vaccines.

Sharan Bobbala1, Viral Tamboli2, Arlene McDowell1, Ashim K Mitra2, Sarah Hook3.   

Abstract

The need for multiple vaccinations to enhance the immunogenicity of subunit vaccines may be reduced by delivering the vaccine over an extended period of time. Here, we report two novel injectable pentablock copolymer based thermoresponsive hydrogels made of polyethyleneglycol-polycaprolactone-polylactide-polycaprolactone-polyethyleneglycol (PEG-PCL-PLA-PCL-PEG) with varying ratios of polycaprolactone (PCL) and polylactide (PLA), as single shot sustained release vaccines. Pentablock copolymer hydrogels were loaded with vaccine-encapsulated poly lactic-co-glycolic acid nanoparticles (PLGA-NP) or with the soluble vaccine components. Incorporation of PLGA-NP into the thermoresponsive hydrogels increased the complex viscosity of the gels, lowered the gelation temperature, and minimized the burst release of antigen and adjuvants. The two pentablock hydrogels stimulated both cellular and humoral responses. The addition of PLGA-NP to the hydrogels sustained immune responses for up to 49 days. The polymer with a higher ratio of PCL to PLA formed a more rigid gel, induced stronger immune responses, and stimulated effective anti-tumor responses in a prophylactic melanoma tumor model.

Entities:  

Keywords:  nanoparticles; pentablock copolymers; sustained release; thermoresponsive hydrogels; vaccine delivery

Mesh:

Substances:

Year:  2015        PMID: 26589309      PMCID: PMC4706273          DOI: 10.1208/s12248-015-9843-4

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  46 in total

Review 1.  Old and new vaccine approaches.

Authors:  Ruth Arnon; Tamar Ben-Yedidia
Journal:  Int Immunopharmacol       Date:  2003-08       Impact factor: 4.932

Review 2.  Vaccines that facilitate antigen entry into dendritic cells.

Authors:  Anita Gamvrellis; David Leong; Jennifer C Hanley; Sue D Xiang; Patricia Mottram; Magdalena Plebanski
Journal:  Immunol Cell Biol       Date:  2004-10       Impact factor: 5.126

3.  Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements.

Authors:  M J Barnden; J Allison; W R Heath; F R Carbone
Journal:  Immunol Cell Biol       Date:  1998-02       Impact factor: 5.126

4.  Biodegradable particles as vaccine delivery systems: size matters.

Authors:  Vijaya B Joshi; Sean M Geary; Aliasger K Salem
Journal:  AAPS J       Date:  2012-10-10       Impact factor: 4.009

Review 5.  Structural and immunological characterization of the vaccine adjuvant QS-21.

Authors:  C R Kensil; J Y Wu; S Soltysik
Journal:  Pharm Biotechnol       Date:  1995

6.  Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma.

Authors:  Andrew J Highton; Thunjiradasiree Kojarunchitt; Adam Girardin; Sarah Hook; Roslyn A Kemp
Journal:  Immunol Cell Biol       Date:  2015-02-24       Impact factor: 5.126

7.  In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery.

Authors:  Sarah Gordon; Elena Teichmann; Katherine Young; Kim Finnie; Thomas Rades; Sarah Hook
Journal:  Eur J Pharm Sci       Date:  2010-07-13       Impact factor: 4.384

Review 8.  Immune system targeting by biodegradable nanoparticles for cancer vaccines.

Authors:  Joana M Silva; Mafalda Videira; Rogério Gaspar; Véronique Préat; Helena F Florindo
Journal:  J Control Release       Date:  2013-03-21       Impact factor: 9.776

9.  Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels.

Authors:  A Paavola; J Yliruusi; P Rosenberg
Journal:  J Control Release       Date:  1998-03-02       Impact factor: 9.776

10.  Tailor-made pentablock copolymer based formulation for sustained ocular delivery of protein therapeutics.

Authors:  Sulabh P Patel; Ravi Vaishya; Gyan Prakash Mishra; Viral Tamboli; Dhananjay Pal; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2014-06-22
View more
  7 in total

1.  Virus-driven Inflammation Is Associated With the Development of bNAbs in Spontaneous Controllers of HIV.

Authors:  Anne-Sophie Dugast; Kelly Arnold; Giuseppe Lofano; Sarah Moore; Michelle Hoffner; Melissa Simek; Pascal Poignard; Michael Seaman; Todd J Suscovich; Florencia Pereyra; Bruce D Walker; Doug Lauffenburger; Douglas S Kwon; Brandon F Keele; Galit Alter
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

2.  Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.

Authors:  Parker W Lee; Sourabh Shukla; Jaqueline D Wallat; Chaitanya Danda; Nicole F Steinmetz; Joao Maia; Jonathan K Pokorski
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

Review 3.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

4.  Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications.

Authors:  Noah Pacifici; Amir Bolandparvaz; Jamal S Lewis
Journal:  Adv Ther (Weinh)       Date:  2020-08-02

Review 5.  Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines.

Authors:  Lu Han; Ke Peng; Li-Ying Qiu; Meng Li; Jing-Hua Ruan; Li-Li He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

6.  Green Synthesis of Thermo-Responsive Hydrogel from Oil Palm Empty Fruit Bunches Cellulose for Sustained Drug Delivery.

Authors:  Maha Mohammad Al-Rajabi; Yeit Haan Teow
Journal:  Polymers (Basel)       Date:  2021-06-29       Impact factor: 4.329

Review 7.  Injectable Hydrogels for Cancer Therapy over the Last Decade.

Authors:  Giuseppe Cirillo; Umile Gianfranco Spizzirri; Manuela Curcio; Fiore Pasquale Nicoletta; Francesca Iemma
Journal:  Pharmaceutics       Date:  2019-09-19       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.